These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 17289495)

  • 1. Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery.
    Murphy GS; Marymont JH
    J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):113-26. PubMed ID: 17289495
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management.
    Shantsila E; Lip GYH; Chong BH
    Chest; 2009 Jun; 135(6):1651-1664. PubMed ID: 19497901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heparin induced thrombocytopenia and anticoagulation in renal replacemant therapy].
    Steinfeldt T; Rolfes C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2008 Apr; 43(4):304-10; quiz 312. PubMed ID: 18409125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current treatment concepts in heparin-induced thrombocytopenia].
    Ranze O; Greinacher A
    Dtsch Med Wochenschr; 1999 Jul; 124(28-29):865-73. PubMed ID: 10432950
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiopulmonary bypass with danaparoid sodium and ancrod in heparin-induced thrombocytopenia.
    Kanagasabay RR; Unsworth-White MJ; Robinson G; Bevan D; Farnsworth G; Haxby EJ; Smith EE
    Ann Thorac Surg; 1998 Aug; 66(2):567-9. PubMed ID: 9725413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
    Garcia DA; Baglin TP; Weitz JI; Samama MM
    Chest; 2012 Feb; 141(2 Suppl):e24S-e43S. PubMed ID: 22315264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-induced thrombocytopenia and thrombosis.
    Patel VP; Bong M; Di Cesare PE
    Am J Orthop (Belle Mead NJ); 2007 May; 36(5):255-60. PubMed ID: 17571830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of danaparoid sodium (Orgaran) as an alternative to heparin sodium during cardiopulmonary bypass: a clinical evaluation of six cases.
    Fernandes P; Mayer R; MacDonald JL; Cleland AG; Hay-McKay C
    Perfusion; 2000 Nov; 15(6):531-9. PubMed ID: 11131218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects.
    Castelli R; Cassinerio E; Cappellini MD; Porro F; Graziadei G; Fabris F
    Cardiovasc Hematol Disord Drug Targets; 2007 Sep; 7(3):153-62. PubMed ID: 17896955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Hirsh J; Bauer KA; Donati MB; Gould M; Samama MM; Weitz JI
    Chest; 2008 Jun; 133(6 Suppl):141S-159S. PubMed ID: 18574264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifesaving citrate anticoagulation to bridge ineffective danaparoid [correction of to bridge to danaparoid] treatment.
    Dworschak M; Hiesmayr JM; Lassnigg A
    Ann Thorac Surg; 2002 May; 73(5):1626-7. PubMed ID: 12022563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-induced thrombocytopenia and cardiovascular diseases.
    Das P; Ziada K; Steinhubl SR; Moliterno DJ; Hamdalla H; Jozic J; Mukherjee D
    Am Heart J; 2006 Jul; 152(1):19-26. PubMed ID: 16824828
    [No Abstract]   [Full Text] [Related]  

  • 13. Orgaran (Org 10172) for cardiopulmonary bypass in heparin-induced thrombocytopenia: role of adjunctive plasmapheresis.
    Schmahl KS; Ganjoo AK; Harloff MG
    J Cardiothorac Vasc Anesth; 1997 Apr; 11(2):262-3. PubMed ID: 9106004
    [No Abstract]   [Full Text] [Related]  

  • 14. Coagulation complicating cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia receiving the heparinoid, danaparoid sodium.
    Grocott HP; Root J; Berkowitz SD; deBruijn N; Landolfo K
    J Cardiothorac Vasc Anesth; 1997 Dec; 11(7):875-7. PubMed ID: 9412888
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of heparin-induced thrombocytopenia in cardiovascular patients.
    Matthai WH
    Expert Opin Pharmacother; 2006 Feb; 7(3):267-76. PubMed ID: 16448321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hitting back HIT.
    Gude D
    Ann Card Anaesth; 2012; 15(2):168-9. PubMed ID: 22508216
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of low molecular weight heparins by dermatologists].
    Maakaroun A; Gruel Y
    Ann Dermatol Venereol; 2003 Apr; 130(4):473-8. PubMed ID: 12843865
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct thrombin inhibitors in patients with mechanical heart valves: ready for clinical trials?
    Rupprecht HJ
    Thromb Haemost; 2009 Jun; 101(6):995-6. PubMed ID: 19492137
    [No Abstract]   [Full Text] [Related]  

  • 19. [Successful therapy of heparin-associated thrombocytopenia with a low sulfated heparinoid].
    Herzog S; Rath W; Kuhn W
    Geburtshilfe Frauenheilkd; 1995 Mar; 55(3):164-6. PubMed ID: 7665065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-induced thrombocytopenia: what clinicians need to know.
    Chong BH; Isaacs A
    Thromb Haemost; 2009 Feb; 101(2):279-83. PubMed ID: 19190810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.